DOI QR코드

DOI QR Code

Perioperative red blood cell transfusion in orofacial surgery

  • Park, So-Young (Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seo, Kwang-Suk (Department of Dental Anesthesiology, Seoul National University Dental Hospital) ;
  • Karm, Myong-Hwan (Department of Dental Anesthesiology, Seoul National University Dental Hospital)
  • Received : 2017.08.12
  • Accepted : 2017.09.03
  • Published : 2017.09.30

Abstract

In the field of orofacial surgery, a red blood cell transfusion (RBCT) is occasionally required during double jaw and oral cancer surgery. However, the question remains whether the effect of RBCT during the perioperative period is beneficial or harmful. The answer to this question remains challenging. In the field of orofacial surgery, transfusion is performed for the purpose of oxygen transfer to hypoxic tissues and plasma volume expansion when there is bleeding. However, there are various risks, such as infectious complications (viral and bacterial), transfusion-related acute lung injury, ABO and non-ABO associated hemolytic transfusion reactions, febrile non-hemolytic transfusion reactions, transfusion associated graft-versus-host disease, transfusion associated circulatory overload, and hypersensitivity transfusion reaction including anaphylaxis and transfusion-related immune-modulation. Many studies and guidelines have suggested RBCT is considered when hemoglobin levels recorded are 7 g/dL for general patients and 8-9 g/dL for patients with cardiovascular disease or hemodynamically unstable patients. However, RBCT is occasionally an essential treatment during surgeries and it is often required in emergency cases. We need to comprehensively consider postoperative bleeding, different clinical situations, the level of intra- and postoperative patient monitoring, and various problems that may arise from a transfusion, in the perspective of patient safety. Since orofacial surgery has an especially high risk of bleeding due to the complex structures involved and the extensive vascular distribution, measures to prevent bleeding should be taken and the conditions for a transfusion should be optimized and appropriate in order to promote patient safety.

Keywords

References

  1. Vamvakas EC, Blajchman MA. Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17. https://doi.org/10.1182/blood-2008-10-167643
  2. Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet 2013; 381: 1845-54. https://doi.org/10.1016/S0140-6736(13)60650-9
  3. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507. https://doi.org/10.1001/jama.288.12.1499
  4. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The crit study: Anemia and blood transfusion in the critically ill--current clinical practice in the united states. Crit Care Med 2004; 32: 39-52. https://doi.org/10.1097/01.CCM.0000104112.34142.79
  5. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in european intensive care units: Results of the soap study. Crit Care Med 2006; 34: 344-53. https://doi.org/10.1097/01.CCM.0000194725.48928.3A
  6. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, canadian critical care trials group. N Engl J Med 1999; 340: 409-17. https://doi.org/10.1056/NEJM199902113400601
  7. Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, et al. The premature infants in need of transfusion (pint) study: A randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006; 149: 301-7. https://doi.org/10.1016/j.jpeds.2006.05.011
  8. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: The tracs randomized controlled trial. JAMA 2010; 304: 1559-67. https://doi.org/10.1001/jama.2010.1446
  9. Schmidt PJ, Ness PM. Hemotherapy: From bloodletting magic to transfusion medicine. Transfusion 2006; 46: 166-8. https://doi.org/10.1111/j.1537-2995.2006.00697.x
  10. Valeri CR, Khuri S, Ragno G. Role of the hct in the treatment of thrombocytopenic patients. Transfusion 2003; 43: 1761-3; author reply 3. https://doi.org/10.1111/j.0041-1132.2003.00595.x
  11. Cines DB, Lebedeva T, Nagaswami C, Hayes V, Massefski W, Litvinov RI, et al. Clot contraction: Compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 2014; 123: 1596-603. https://doi.org/10.1182/blood-2013-08-523860
  12. Perioperative red cell transfusion. Natl Inst Health Consens Dev Conf Consens Statement 1988; 7: 1-6.
  13. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: Indications and complications. Am Fam Physician 2011; 83: 719-24.
  14. Hogshire L, Carson JL. Red blood cell transfusion: What is the evidence when to transfuse? Curr Opin Hematol 2013; 20: 546-51. https://doi.org/10.1097/MOH.0b013e32836508bd
  15. Liumbruno GM, Vaglio S, Biancofiore G, Marano G, Mengoli C, Franchini M. Transfusion thresholds and beyond. Blood Transfus 2016; 14: 123-5.
  16. Freedman J. Transfusion--whence and why. Transfus Apher Sci 2014; 50: 5-9. https://doi.org/10.1016/j.transci.2013.12.003
  17. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-91. https://doi.org/10.1056/NEJMoa1406617
  18. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21. https://doi.org/10.1056/NEJMoa1211801
  19. Jairath V, Kahan BC, Gray A, Dore CJ, Mora A, James MW, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (trigger): A pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015; 386: 137-44. https://doi.org/10.1016/S0140-6736(14)61999-1
  20. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62. https://doi.org/10.1056/NEJMoa1012452
  21. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis. JAMA 2014; 311: 1317-26. https://doi.org/10.1001/jama.2014.2726
  22. Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC, et al. Practice parameter for the use of red blood cell transfusions: Developed by the red blood cell administration practice guideline development task force of the college of american pathologists. Arch Pathol Lab Med 1998; 122: 130-8.
  23. Management ASoATFoPB. Practice guidelines for perioperative blood management: An updated report by the american society of anesthesiologists task force on perioperative blood management*. Anesthesiology 2015; 122: 241-75. https://doi.org/10.1097/ALN.0000000000000463
  24. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. Iii. The post-operative period. Blood Transfus 2011; 9: 320-35.
  25. Napolitano LM, Kurek S, Luchette FA, Anderson GL, Bard MR, Bromberg W, et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. J Trauma 2009; 67: 1439-42. https://doi.org/10.1097/TA.0b013e3181ba7074
  26. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37: 3124-57. https://doi.org/10.1097/CCM.0b013e3181b39f1b
  27. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82. https://doi.org/10.1016/j.athoracsur.2010.11.078
  28. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012; 107: 345-60; quiz 61. https://doi.org/10.1038/ajg.2011.480
  29. Alexander J, Cifu AS. Transfusion of red blood cells. JAMA 2016; 316: 2038-9. https://doi.org/10.1001/jama.2016.12870
  30. Centre NCG. Acute upper gastrointestinal bleeding. (evidence update august 2014. A summary of selected new evidence relevant to nice clinical guideline 141. Evidence update 63). London: Royal College of Physicians 2012.
  31. Excellence TNIfHaC. Blood transfusion nice guideline. Available at: https://wwwniceorguk/guidance/ng24 Accessed on 31/03/2017.
  32. Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: Guidelines from the european society of anaesthesiology: First update 2016. Eur J Anaesthesiol 2017; 34: 332-95. https://doi.org/10.1097/EJA.0000000000000630
  33. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. Esc guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: The task force for the management of acute coronary syndromes (acs) in patients presenting without persistent st-segment elevation of the european society of cardiology (esc). Eur Heart J 2011; 32: 2999-3054. https://doi.org/10.1093/eurheartj/ehr236
  34. Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P. Treatment of anemia in patients with heart disease: A clinical practice guideline from the american college of physicians. Ann Intern Med 2013; 159: 770-9. https://doi.org/10.7326/0003-4819-159-11-201312030-00009
  35. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the aabb: Red blood cell transfusion thresholds and storage. JAMA 2016; 316: 2025-35. https://doi.org/10.1001/jama.2016.9185
  36. Berkow L, Rotolo S, Mirski E. Continuous noninvasive hemoglobin monitoring during complex spine surgery. Anesth Analg 2011; 113: 1396-402. https://doi.org/10.1213/ANE.0b013e318230b425
  37. Miller RD, Ward TA, Shiboski SC, Cohen NH. A comparison of three methods of hemoglobin monitoring in patients undergoing spine surgery. Anesth Analg 2011; 112: 858-63. https://doi.org/10.1213/ANE.0b013e31820eecd1
  38. Kim SH, Choi JM, Kim HJ, Choi SS, Choi IC. Continuous noninvasive hemoglobin measurement is useful in patients undergoing double-jaw surgery. J Oral Maxillofac Surg 2014; 72: 1813-9. https://doi.org/10.1016/j.joms.2014.03.011
  39. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med 2008; 36: 2667-74. https://doi.org/10.1097/CCM.0b013e3181844677
  40. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010; 50: 2080-99. https://doi.org/10.1111/j.1537-2995.2010.02851.x
  41. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, et al. Experience of german red cross blood donor services with nucleic acid testing: Results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis c virus, and hepatitis b virus. Transfusion 2008; 48: 1558-66. https://doi.org/10.1111/j.1537-2995.2008.01718.x
  42. Lindholm PF, Annen K, Ramsey G. Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets 2011; 11: 45-56. https://doi.org/10.2174/187152611794407746
  43. Ziemann M, Thiele T. Transfusion-transmitted cmv infection - current knowledge and future perspectives. 2017.
  44. Sharma AD, Slaughter TF, Clements FM, Sreeram G, Newman MF, Phillips-Bute B, et al. Association of leukocyte-depleted blood transfusions with infectious complications after cardiac surgery. Surg Infect (Larchmt) 2002; 3: 127-33. https://doi.org/10.1089/109629602760105790
  45. Zimring JC, Smith N, Stowell SR, Johnsen JM, Bell LN, Francis RO, et al. Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. Transfusion 2014; 54: 137-48. https://doi.org/10.1111/trf.12264
  46. Connell NT. Transfusion medicine. Prim Care 2016; 43: 651-9. https://doi.org/10.1016/j.pop.2016.07.004
  47. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003; 17: 252-62. https://doi.org/10.1016/S0887-7963(03)00039-7
  48. Bux J. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011; 100: 122-8. https://doi.org/10.1111/j.1423-0410.2010.01392.x
  49. Shaz BH, Stowell SR, Hillyer CD. Transfusion-related acute lung injury: From bedside to bench and back. Blood 2011; 117: 1463-71. https://doi.org/10.1182/blood-2010-04-278135
  50. N Franklin Adkinson Jr BSB, Wesley Burks, William W Busse, Stephen T Holgate, Robert F Lemanske Jr, Robyn E O'Hehir. Middleton's allergy principles & practice. 8th edition. Elsevier. 2014; 1152.
  51. Anani W, Triulzi D, Yazer MH, Qu L. Relative iga-deficient recipients have an increased risk of severe allergic transfusion reactions. Vox Sang 2014; 107: 389-92. https://doi.org/10.1111/vox.12192
  52. Popovsky MA, Audet AM, Andrzejewski C, Jr. Transfusion-associated circulatory overload in orthopedic surgery patients: A multi-institutional study. Immunohematology 1996; 12: 87-9.
  53. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest 2010; 137: 209-20. https://doi.org/10.1378/chest.09-0252
  54. Muszynski JA, Spinella PC, Cholette JM, Acker JP, Hall MW, Juffermans NP, et al. Transfusion-related immunomodulation: Review of the literature and implications for pediatric critical illness. Transfusion 2017; 57: 195-206. https://doi.org/10.1111/trf.13855
  55. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (trim): An update. Blood Rev 2007; 21: 327-48. https://doi.org/10.1016/j.blre.2007.07.003
  56. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma 2006; 60: S83-90. https://doi.org/10.1097/01.ta.0000199537.09201.7b
  57. van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Kast WM, et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991; 325: 1210-3. https://doi.org/10.1056/NEJM199110243251704
  58. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-6. https://doi.org/10.1002/bjs.1800790613
  59. Berezina TL, Zaets SB, Morgan C, Spillert CR, Kamiyama M, Spolarics Z, et al. Influence of storage on red blood cell rheological properties. J Surg Res 2002; 102: 6-12. https://doi.org/10.1006/jsre.2001.6306
  60. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 2002; 16: 144-60. https://doi.org/10.1053/tmrv.2002.31463
  61. Dzik WH. Apoptosis, tgf beta and transfusion-related immunosuppression: Biologic versus clinical effects. Transfus Apher Sci 2003; 29: 127-9. https://doi.org/10.1016/S1473-0502(03)00115-0
  62. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil nadph oxidase. J Lab Clin Med 1994; 124: 684-94.
  63. Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, Scharf L, et al. Recognition of lyso-phospholipids by human natural killert lymphocytes. PLoS Biol 2009; 7: e1000228. https://doi.org/10.1371/journal.pbio.1000228
  64. Coutant F, Perrin-Cocon L, Agaugue S, Delair T, Andre P, Lotteau V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol 2002; 169: 1688-95. https://doi.org/10.4049/jimmunol.169.4.1688
  65. Jin Y, Damaj BB, Maghazachi AA. Human resting cd16-, cd16+ and il-2-, il-12-, il-15- or ifn-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and plateletactivating factor. Eur J Immunol 2005; 35: 2699-708. https://doi.org/10.1002/eji.200526129
  66. Olofsson KE, Andersson L, Nilsson J, Bjorkbacka H. Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun 2008; 370: 348-52. https://doi.org/10.1016/j.bbrc.2008.03.087
  67. Jacobi KE, Wanke C, Jacobi A, Weisbach V, Hemmerling TM. Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. J Clin Anesth 2000; 12: 94-9. https://doi.org/10.1016/S0952-8180(00)00122-7
  68. Gately S, Li WW. Multiple roles of cox-2 in tumor angiogenesis: A target for antiangiogenic therapy. Semin Oncol 2004; 31: 2-11. https://doi.org/10.1053/S0093-7754(04)00315-X
  69. Mulligan JK, Rosenzweig SA, Young MR. Tumor secretion of vegf induces endothelial cells to suppress t cell functions through the production of pge2. J Immunother 2010; 33: 126-35. https://doi.org/10.1097/CJI.0b013e3181b91c9c
  70. Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, et al. Pge (2) contributes to tgf-beta induced t regulatory cell function in human non-small cell lung cancer. Am J Transl Res 2010; 2: 356-67.
  71. Soontrapa K, Honda T, Sakata D, Yao C, Hirata T, Hori S, et al. Prostaglandin e2-prostaglandin e receptor subtype 4 (ep4) signaling mediates uv irradiation-induced systemic immunosuppression. Proc Natl Acad Sci U S A 2011; 108: 6668-73. https://doi.org/10.1073/pnas.1018625108
  72. Bilgin YM, Brand A. Transfusion-related immunomodulation: A second hit in an inflammatory cascade? Vox Sang 2008; 95: 261-71. https://doi.org/10.1111/j.1423-0410.2008.01100.x
  73. Seghatchian J. Universal leucodepletion: An overview of some unresolved issues and the highlights of lessons learned. Transfus Apher Sci 2003; 29: 105-17. https://doi.org/10.1016/S1473-0502(03)00112-5
  74. Baumgartner JM, Nydam TL, Clarke JH, Banerjee A, Silliman CC, McCarter MD. Red blood cell supernatant potentiates lps-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res 2009; 29: 333-8. https://doi.org/10.1089/jir.2008.0072
  75. Karam O, Tucci M, Toledano BJ, Robitaille N, Cousineau J, Thibault L, et al. Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion 2009; 49: 2326-34. https://doi.org/10.1111/j.1537-2995.2009.02319.x
  76. Patel MB, Proctor KG, Majetschak M. Extracellular ubiquitin increases in packed red blood cell units during storage. J Surg Res 2006; 135: 226-32. https://doi.org/10.1016/j.jss.2006.04.037
  77. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. Cd4+cd25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-53. https://doi.org/10.4049/jimmunol.167.3.1245
  78. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory t cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197: 403-11. https://doi.org/10.1084/jem.20021633
  79. Chen W, Frank ME, Jin W, Wahl SM. Tgf-beta released by apoptotic t cells contributes to an immunosuppressive milieu. Immunity 2001; 14: 715-25. https://doi.org/10.1016/S1074-7613(01)00147-9
  80. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserinespecific clearance of apoptotic cells. Nature 2000; 405: 85-90. https://doi.org/10.1038/35011084
  81. Saas P, Bonnefoy F, Kury-Paulin S, Kleinclauss F, Perruche S. Mediators involved in the immunomodulatory effects of apoptotic cells. Transplantation 2007; 84: S31-4. https://doi.org/10.1097/01.tp.0000269113.59857.d6
  82. Saas P, Angelot F, Bardiaux L, Seilles E, Garnache-Ottou F, Perruche S. Phosphatidylserine-expressing cell byproducts in transfusion: A pro-inflammatory or an anti-inflammatory effect? Transfus Clin Biol 2012; 19: 90-7. https://doi.org/10.1016/j.tracli.2012.02.002
  83. McDonald PP, Fadok VA, Bratton D, Henson PM. Transcriptional and translational regulation of inflammatory mediator production by endogenous tgf-beta in macrophages that have ingested apoptotic cells. J Immunol 1999; 163: 6164-72.
  84. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799-803. https://doi.org/10.1056/NEJM197810122991503
  85. Williams JG, Hughes LE. Effect of perioperative blood transfusion on recurrence of crohn's disease. Lancet 1989; 2: 131-3.
  86. Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, et al. Use of epoetin and darbepoetin in patients with cancer: 2007 american society of clinical oncology/american society of hematology clinical practice guideline update. J Clin Oncol 2008; 26: 132-49. https://doi.org/10.1200/JCO.2007.14.3396
  87. Cata JP, Chukka V, Wang H, Feng L, Gottumukkala V, Martinez F, et al. Perioperative blood transfusions and survival in patients with non-small cell lung cancer: A retrospective study. BMC Anesthesiol 2013; 13: 42. https://doi.org/10.1186/1471-2253-13-42
  88. Goubran HA, Kotb RR, Stakiw J, Emara ME, Burnouf T. Regulation of tumor growth and metastasis: The role of tumor microenvironment. Cancer Growth Metastasis 2014; 7: 9-18.
  89. De Oliveira GS, Jr., Schink JC, Buoy C, Ahmad S, Fitzgerald PC, McCarthy RJ. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer. Transfus Med 2012; 22: 97-103. https://doi.org/10.1111/j.1365-3148.2011.01122.x
  90. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: A systematic review and meta-analysis. Ann Surg 2012; 256: 235-44. https://doi.org/10.1097/SLA.0b013e31825b35d5
  91. Vamvakas EC. Allogeneic blood transfusion and cancer recurrence: 20 years later. Transfusion 2014; 54: 2149-53. https://doi.org/10.1111/trf.12689
  92. Goubran HA, Burnouf T, Radosevic M, El-Ekiaby M. The platelet-cancer loop. Eur J Intern Med 2013; 24: 393-400. https://doi.org/10.1016/j.ejim.2013.01.017
  93. Goubran HA, Burnouf T, Stakiw J, Seghatchian J. Platelet microparticle: A sensitive physiological "fine tuning" balancing factor in health and disease. Transfus Apher Sci 2015; 52: 12-8. https://doi.org/10.1016/j.transci.2014.12.015
  94. Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T. Platelet microparticles and cancer: An intimate cross-talk. Transfus Apher Sci 2015; 53: 168-72. https://doi.org/10.1016/j.transci.2015.10.014
  95. Drabsch Y, ten Dijke P. Tgf-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev 2012; 31: 553-68. https://doi.org/10.1007/s10555-012-9375-7
  96. Connolly EC, Freimuth J, Akhurst RJ. Complexities of tgf-beta targeted cancer therapy. Int J Biol Sci 2012; 8: 964-78. https://doi.org/10.7150/ijbs.4564
  97. Morner ME, Edgren G, Martling A, Gunnarsson U, Egenvall M. Preoperative anaemia and perioperative red blood cell transfusion as prognostic factors for recurrence and mortality in colorectal cancer-a swedish cohort study. Int J Colorectal Dis 2017; 32: 223-32. https://doi.org/10.1007/s00384-016-2678-3
  98. Nathanson SD, Tilley BC, Schultz L, Smith RF. Perioperative allogeneic blood transfusions. Survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985; 120: 734-8. https://doi.org/10.1001/archsurg.1985.01390300076013
  99. Weiden PL, Bean MA, Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 1987; 60: 870-4. https://doi.org/10.1002/1097-0142(19870815)60:4<870::AID-CNCR2820600425>3.0.CO;2-0
  100. Donohue JH, Williams S, Cha S, Windschitl HE, Witzig TE, Nelson H, et al. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: A mayo/north central cancer treatment group study. J Clin Oncol 1995; 13: 1671-8. https://doi.org/10.1200/JCO.1995.13.7.1671
  101. Wiig JN. [blood transfusion in cancer of the colon and rectum. Friend or foe of the surgeon? A review]. Tidsskr Nor Laegeforen 1990; 110: 503-7.
  102. Deleplanque G, Deleplanque P, Kraimps JL, Carretier M, Barbier J. [prognostic incidence of blood transfusion in 753 patients operated for colorectal adenocarcinoma]. Ann Chir 1992; 46: 584-91.
  103. Faenza A, Cunsolo A, Selleri S, Lucarelli S, Farneti PA, Gozzetti G. Correlation between plasma or blood transfusion and survival after curative surgery for colorectal cancer. Int Surg 1992; 77: 264-9.
  104. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993; 80: 427-32. https://doi.org/10.1002/bjs.1800800407
  105. Steup WH, Hojo K, Moriya Y, Sugihara K, Mizuno S, Hermans J, et al. An analysis on the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer. Hepatogastroenterology 1994; 41: 253-9.
  106. Qiu L, Wang DR, Zhang XY, Gao S, Li XX, Sun GP, et al. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients. Transfus Apher Sci 2016; 54: 235-41. https://doi.org/10.1016/j.transci.2015.07.004
  107. Li XX, Meng J, Sun GP, Tang YX, Liang GF, Wang MF, et al. Effects of perioperative blood transfusion on the prognosis in hereditary and sporadic colon cancer. Biomarkers 2015; 20: 481-6. https://doi.org/10.3109/1354750X.2015.1096306
  108. Kaneko M, Sasaki S, Ishimaru K, Terai E, Nakayama H, Watanabe T. The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer. Anticancer Res 2015; 35: 3553-8.
  109. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988; 75: 789-92. https://doi.org/10.1002/bjs.1800750822
  110. Vamvakas EC, Carven JH, Hibberd PL. Blood transfusion and infection after colorectal cancer surgery. Transfusion 1996; 36: 1000-8. https://doi.org/10.1046/j.1537-2995.1996.36111297091746.x
  111. Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch KW, Thasler WE. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 2015; 58: 74-82. https://doi.org/10.1097/DCR.0000000000000233
  112. Hallet J, Tsang M, Cheng ES, Habashi R, Kulyk I, Hanna SS, et al. The impact of perioperative red blood cell transfusions on long-term outcomes after hepatectomy for colorectal liver metastases. Ann Surg Oncol 2015; 22: 4038-45. https://doi.org/10.1245/s10434-015-4477-4
  113. Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: A meta-analysis. PLoS One 2013; 8: e64261. https://doi.org/10.1371/journal.pone.0064261
  114. Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999; 23: 676-80. https://doi.org/10.1007/PL00012367
  115. Makino Y, Yamanoi A, Kimoto T, El-Assal ON, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 2000; 95: 1294-300. https://doi.org/10.1111/j.1572-0241.2000.02028.x
  116. Sun C, Wang Y, Yao HS, Hu ZQ. Allogeneic blood transfusion and the prognosis of gastric cancer patients: Systematic review and meta-analysis. Int J Surg 2015; 13: 102-10. https://doi.org/10.1016/j.ijsu.2014.11.044
  117. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994; 167: 256-60. https://doi.org/10.1016/0002-9610(94)90087-6
  118. Hyung WJ, Noh SH, Shin DW, Huh J, Huh BJ, Choi SH, et al. Adverse effects of perioperative transfusion on patients with stage iii and iv gastric cancer. Ann Surg Oncol 2002; 9: 5-12. https://doi.org/10.1245/aso.2002.9.1.5
  119. Kosumi K, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H. Perioperative blood transfusion, age at surgery, and prognosis in a database of 526 upper gastrointestinal cancers. Dig Surg 2015; 32: 445-53. https://doi.org/10.1159/000433609
  120. Dresner SM, Lamb PJ, Shenfine J, Hayes N, Griffin SM. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000; 26: 492-7. https://doi.org/10.1053/ejso.1999.0929
  121. Langley SM, Alexiou C, Bailey DH, Weeden DF. The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma. Ann Thorac Surg 2002; 73: 1704-9. https://doi.org/10.1016/S0003-4975(02)03508-7
  122. Reeh M, Ghadban T, Dedow J, Vettorazzi E, Uzunoglu FG, Nentwich M, et al. Allogenic blood transfusion is associated with poor perioperative and long-term outcome in esophageal cancer. World J Surg 2017; 41: 208-15. https://doi.org/10.1007/s00268-016-3730-8
  123. Lim MC, Kim JY, Kim TH, Park S, Kong SY, Yoon JH, et al. Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer. Yonsei Med J 2008; 49: 993-1003. https://doi.org/10.3349/ymj.2008.49.6.993
  124. Santin AD, Bellone S, Parrish RS, Coke C, Dunn D, Roman J, et al. Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest 2003; 56: 28-34. https://doi.org/10.1159/000072328
  125. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013; 63: 839-45. https://doi.org/10.1016/j.eururo.2013.01.004
  126. Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A, et al. Perioperative blood transfusion adversely affects prognosis of patients with stage i non-small-cell lung cancer. Am J Surg 1990; 160: 630-2; discussion 3. https://doi.org/10.1016/S0002-9610(05)80762-7
  127. Perisanidis C, Dettke M, Papadogeorgakis N, Schoppmann A, Mittlbock M, Kyzas PA, et al. Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. Oral Oncol 2012; 48: 372-8. https://doi.org/10.1016/j.oraloncology.2011.11.020
  128. Karakida K, Aoki T, Ota Y, Yamazaki H, Otsuru M, Takahashi M, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 2010; 16: 334-9. https://doi.org/10.1007/s10156-010-0108-y
  129. Liu SA, Wong YK, Poon CK, Wang CC, Wang CP, Tung KC. Risk factors for wound infection after surgery in primary oral cavity cancer patients. Laryngoscope 2007; 117: 166-71. https://doi.org/10.1097/01.mlg.0000249737.05840.29
  130. Taniguchi Y, Okura M. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head Neck 2003; 25: 931-6. https://doi.org/10.1002/hed.10313
  131. Szakmany T, Dodd M, Dempsey GA, Lowe D, Brown JS, Vaughan ED, et al. The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma. Br J Cancer 2006; 94: 647-53. https://doi.org/10.1038/sj.bjc.6603013
  132. Chau JK, Harris JR, Seikaly HR. Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. J Otolaryngol Head Neck Surg 2010; 39: 516-22.
  133. Ervens J, Marks C, Hechler M, Plath T, Hansen D, Hoffmeister B. Effect of induced hypotensive anaesthesia vs isovolaemic haemodilution on blood loss and transfusion requirements in orthognathic surgery: A prospective, single-blinded, randomized, controlled clinical study. Int J Oral Maxillofac Surg 2010; 39: 1168-74. https://doi.org/10.1016/j.ijom.2010.09.003
  134. Choi WS, Samman N. Risks and benefits of deliberate hypotension in anaesthesia: A systematic review. Int J Oral Maxillofac Surg 2008; 37: 687-703. https://doi.org/10.1016/j.ijom.2008.03.011
  135. Varol A, Basa S, Ozturk S. The role of controlled hypotension upon transfusion requirement during maxillary downfracture in double-jaw surgery. J Craniomaxillofac Surg 2010; 38: 345-9. https://doi.org/10.1016/j.jcms.2009.10.012
  136. Zellin G, Rasmusson L, Palsson J, Kahnberg KE. Evaluation of hemorrhage depressors on blood loss during orthognathic surgery: A retrospective study. J Oral Maxillofac Surg 2004; 62: 662-6. https://doi.org/10.1016/j.joms.2004.02.001
  137. Sankar D, Krishnan R, Veerabahu M, Vikraman B. Evaluation of the efficacy of tranexamic acid on blood loss in orthognathic surgery. A prospective, randomized clinical study. Int J Oral Maxillofac Surg 2012; 41: 713-7. https://doi.org/10.1016/j.ijom.2012.01.008
  138. Ramos E, Dalmau A, Sabate A, Lama C, Llado L, Figueras J, et al. Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320-7. https://doi.org/10.1016/jlts.2003.50204
  139. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74: 1180-6. https://doi.org/10.1016/S0003-4975(02)03766-9
  140. Kleczynski P, Dziewierz A, Bagienski M, Rzeszutko L, Sorysz D, Trebacz J, et al. Association between blood transfusions and 12-month mortality after transcatheter aortic valve implantation. Int Heart J 2017; 58: 50-5. https://doi.org/10.1536/ihj.16-131
  141. Bursi F, Barbieri A, Politi L, Di Girolamo A, Malagoli A, Grimaldi T, et al. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. Eur J Vasc Endovasc Surg 2009; 37: 311-8. https://doi.org/10.1016/j.ejvs.2008.12.002
  142. Weber EW, Slappendel R, Prins MH, van der Schaaf DB, Durieux ME, Strumper D. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: Effects on duration of hospitalization. Anesth Analg 2005; 100: 1416-21, table of contents. https://doi.org/10.1213/01.ANE.0000150610.44631.9D
  143. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 u to 2 u packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-7, 7.e1-2; discussion 8-9. https://doi.org/10.1016/j.jamcollsurg.2008.11.019
  144. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55. https://doi.org/10.1001/archsurg.2011.790
  145. de Almeida JP, Vincent JL, Galas FR, de Almeida EP, Fukushima JT, Osawa EA, et al. Transfusion requirements in surgical oncology patients: A prospective, randomized controlled trial. Anesthesiology 2015; 122: 29-38. https://doi.org/10.1097/ALN.0000000000000511
  146. Samman N, Cheung LK, Tong AC, Tideman H. Blood loss and transfusion requirements in orthognatic surgery. J Oral Maxillofac Surg 1996; 54: 21-4; discussion 5-6. https://doi.org/10.1016/S0278-2391(96)90295-5
  147. Gong SG, Krishnan V, Waack D. Blood transfusions in bimaxillary orthognathic surgery: Are they necessary? Int J Adult Orthodon Orthognath Surg 2002; 17: 314-7.
  148. Ueki K, Marukawa K, Shimada M, Nakagawa K, Yamamoto E. The assessment of blood loss in orthognathic surgery for prognathia. J Oral Maxillofac Surg 2005; 63: 350-4. https://doi.org/10.1016/j.joms.2004.05.226
  149. Stewart A, Newman L, Sneddon K, Harris M. Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery. Br J Oral Maxillofac Surg 2001; 39: 365-70. https://doi.org/10.1054/bjom.2001.0664
  150. Moenning JE, Bussard DA, Lapp TH, Garrison BT. Average blood loss and the risk of requiring perioperative blood transfusion in 506 orthognathic surgical procedures. J Oral Maxillofac Surg 1995; 53: 880-3. https://doi.org/10.1016/0278-2391(95)90273-2
  151. Kramer FJ, Baethge C, Swennen G, Teltzrow T, Schulze A, Berten J, et al. Intra- and perioperative complications of the lefort i osteotomy: A prospective evaluation of 1000 patients. J Craniofac Surg 2004; 15: 971-7; discussion 8-9. https://doi.org/10.1097/00001665-200411000-00016
  152. Flood TR, Ilankovan V, Moos KF, el-Attar A. Cross-match requirements in orthognathic surgery: An audit. Br J Oral Maxillofac Surg 1990; 28: 292-4. https://doi.org/10.1016/0266-4356(90)90099-7
  153. Tang ZL, Wang X, Yi B, Li ZL, Liang C, Wang XX. Effects of the preoperative administration of yunnan baiyao capsules on intraoperative blood loss in bimaxillary orthognathic surgery: A prospective, randomized, doubleblind, placebo-controlled study. Int J Oral Maxillofac Surg 2009; 38: 261-6. https://doi.org/10.1016/j.ijom.2008.12.003
  154. Faverani LP, Ramalho-Ferreira G, Fabris AL, Polo TO, Poli GH, Pastori CM, et al. Intraoperative blood loss and blood transfusion requirements in patients undergoing orthognathic surgery. Oral Maxillofac Surg 2014; 18: 305-10. https://doi.org/10.1007/s10006-013-0415-4
  155. Garcia-Roa M, Del Carmen Vicente-Ayuso M, Bobes AM, Pedraza AC, Gonzalez-Fernandez A, Martin MP, et al. Red blood cell storage time and transfusion: Current practice, concerns and future perspectives. Blood Transfus 2017; 15: 222-31.
  156. Cancelas JA, Dumont LJ, Maes LA, Rugg N, Herschel L, Whitley PH, et al. Additive solution-7 reduces the red blood cell cold storage lesion. Transfusion 2015; 55: 491-8. https://doi.org/10.1111/trf.12867
  157. Hess JR, Rugg N, Knapp AD, Gormas JF, Silberstein EB, Greenwalt TJ. Successful storage of rbcs for 9 weeks in a new additive solution. Transfusion 2000; 40: 1007-11. https://doi.org/10.1046/j.1537-2995.2000.40081007.x
  158. Antonelou MH, Kriebardis AG, Papassideri IS. Aging and death signalling in mature red cells: From basic science to transfusion practice. Blood Transfus 2010; 8 Suppl 3: s39-47.
  159. Blasi B, D'Alessandro A, Ramundo N, Zolla L. Red blood cell storage and cell morphology. Transfus Med 2012; 22: 90-6. https://doi.org/10.1111/j.1365-3148.2012.01139.x
  160. D'Alessandro A, D'Amici GM, Vaglio S, Zolla L. Time-course investigation of sagm-stored leukocytefiltered red bood cell concentrates: From metabolism to proteomics. Haematologica 2012; 97: 107-15. https://doi.org/10.3324/haematol.2011.051789
  161. Bosman GJ, Werre JM, Willekens FL, Novotny VM. Erythrocyte ageing in vivo and in vitro: Structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-47. https://doi.org/10.1111/j.1365-3148.2008.00892.x
  162. Hod EA, Godbey EA. The outsider adverse event in transfusion: Inflammation. Presse Med 2016; 45: e325-9. https://doi.org/10.1016/j.lpm.2016.06.025
  163. van de Watering L. Red cell storage and prognosis. Vox Sang 2011; 100: 36-45. https://doi.org/10.1111/j.1423-0410.2010.01441.x
  164. Eikelboom JW, Cook RJ, Barty R, Liu Y, Arnold DM, Crowther MA, et al. Rationale and design of the informing fresh versus old red cell management (inform) trial: An international pragmatic randomized trial. Transfus Med Rev 2016; 30: 25-9. https://doi.org/10.1016/j.tmrv.2015.11.002
  165. Shah A, McKechnie S, Brunskill SJ, Stanworth SJ. Fresh versus old red cell transfusions: What have the recent clinical trials found? Curr Opin Hematol 2016; 23: 550-6. https://doi.org/10.1097/MOH.0000000000000283
  166. Chalfin HJ, Frank SM, Feng Z, Trock BJ, Drake CG, Partin AW, et al. Allogeneic versus autologous blood transfusion and survival after radical prostatectomy. Transfusion 2014; 54: 2168-74. https://doi.org/10.1111/trf.12611
  167. Dietrich W, Thuermel K, Heyde S, Busley R, Berger K. Autologous blood donation in cardiac surgery: Reduction of allogeneic blood transfusion and cost-effectiveness. J Cardiothorac Vasc Anesth 2005; 19: 589-96. https://doi.org/10.1053/j.jvca.2005.04.017
  168. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-67. https://doi.org/10.1200/JCO.1994.12.9.1859
  169. Oh AY, Seo KS, Lee GE, Kim HJ. Effect of preoperative autologous blood donation on patients undergoing bimaxillary orthognathic surgery: A retrospective analysis. Int J Oral Maxillofac Surg 2016; 45: 486-9. https://doi.org/10.1016/j.ijom.2015.11.008
  170. Jakovina Blazekovic S, Bicanic G, Hrabac P, Tripkovic B, Delimar D. Pre-operative autologous blood donation versus no blood donation in total knee arthroplasty: A prospective randomised trial. Int Orthop 2014; 38: 341-6. https://doi.org/10.1007/s00264-013-2185-x
  171. Zhou J. A review of the application of autologous blood transfusion. Braz J Med Biol Res 2016; 49: e5493.
  172. Practice guidelines for blood component therapy: A report by the american society of anesthesiologists task force on blood component therapy. Anesthesiology 1996; 84: 732-47. https://doi.org/10.1097/00000542-199603000-00032
  173. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The international study of perioperative transfusion. Anesth Analg 1998; 86: 9-15.
  174. Barile L, Fominskiy E, Di Tomasso N, Alpizar Castro LE, Landoni G, De Luca M, et al. Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: A systematic review and meta-analysis of randomized trials. Anesth Analg 2017; 124: 743-52. https://doi.org/10.1213/ANE.0000000000001609
  175. Lee JM, Seo KS, Kim HJ, Shin SY. Experience of a bloodless two-jaw surgery and care in jehovah's witnesses with anemia. J Korean Dent Soc Anesthesiol 2012; 12: 25-31. https://doi.org/10.17245/jkdsa.2012.12.1.25
  176. Ickx BE, Rigolet M, Van Der Linden PJ. Cardiovascular and metabolic response to acute normovolemic anemia. Effects of anesthesia. Anesthesiology 2000; 93: 1011-6. https://doi.org/10.1097/00000542-200010000-00024
  177. Hill J, James V. Survey of autologous blood transfusion activity in england (2001). Transfus Med 2003; 13: 9-15. https://doi.org/10.1046/j.1365-3148.2003.00418.x
  178. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010; 105: 401-16. https://doi.org/10.1093/bja/aeq244

Cited by

  1. Discussion : An Assessment of Bleeding Complications Necessitating Blood Transfusion across Inpatient Plastic Surgery Procedures vol.143, pp.5, 2019, https://doi.org/10.1097/prs.0000000000005538
  2. Blood cell-derived extracellular vesicles: diagnostic biomarkers and smart delivery systems vol.12, pp.1, 2017, https://doi.org/10.1080/21655979.2021.1982320